Related Experiment Video
Updated: Mar 3, 2026

Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring
Published on: May 2, 2025
Outcomes in adult Fontan patients with atrial tachyarrhythmias
Alexander C Egbe1, Heidi M Connolly1, Arooj R Khan1
1Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
Insights
For Fontan patients with atrial tachyarrhythmia, catheter ablation and Fontan conversion significantly reduce recurrence compared to antiarrhythmic drugs, leading to fewer adverse events. Early intervention at specialty centers is recommended.
Area of Science:
- Cardiology
- Electrophysiology
- Congenital Heart Disease
Background:
- Optimal management for atrial tachyarrhythmia in Fontan patients remains unclear.
- Fontan-associated arrhythmias pose significant clinical challenges.
Purpose of the Study:
- To compare the efficacy of antiarrhythmic drugs (AAD), catheter ablation (CA), and Fontan conversion (FC) in managing atrial tachyarrhythmia (AR) in adult Fontan patients.
- To evaluate freedom from AR recurrence and the occurrence of adverse events across different treatment strategies.
Main Methods:
- Retrospective review of 264 adult Fontan patients diagnosed with atrial tachyarrhythmia.
- Analysis of patients treated with AAD, CA, or FC, comparing freedom from AR and composite adverse events (stroke, heart failure hospitalization, death, heart transplant).
Main Results:
- Catheter ablation achieved 41% freedom from AR at 60 months; Fontan conversion achieved 51% freedom from AR at 60 months.
- Both CA and FC demonstrated significantly lower AR recurrence rates compared to AAD (7% freedom at 60 months).
- Adverse events were more frequent in patients with recurrent AR and those treated solely with AAD.
Conclusions:
- Catheter ablation and Fontan conversion are superior to antiarrhythmic drugs for managing atrial tachyarrhythmia in Fontan survivors.
- Longer duration of atrial tachyarrhythmia correlates with higher recurrence rates and increased adverse events.
- Prompt referral to specialized centers for CA or FC is advised for improved outcomes.
Background:
The optimal management strategy for atrial tachyarrhythmia in the Fontan population is unknown.
Methods:
Retrospective review of 264 adult Fontan patients with atrial tachyarrhythmia evaluating 3 clinically adopted scenarios: antiarrhythmic drug (AAD) therapy, catheter ablation (CA), and Fontan conversion (FC). These patients were followed up at Mayo Clinic from 1994 to 2014. The study objective was to compare freedom from atrial tachyarrhythmia recurrence (AR) and occurrence of composite adverse events (stroke, heart failure hospitalization, death, or heart transplant) between treatment groups.
Results:
The age of atrial tachyarrhythmia onset was 25 ± 4 years, time from Fontan operation was 13 ± 6 years, follow-up was 74 ± 18 months, atriopulmonary Fontan was 215 (81%), and atrial flutter/intra-atrial reentry tachycardia was 173 (65%). In those managed with AAD (n = 110), freedom from AR was 7% at 60 months. Catheter ablation (n = 31) was associated with an acute procedural success of 94%, and freedom from AR was 41% at 60 months. Fontan conversion (n = 33) resulted in a perioperative mortality of 3%, and freedom from AR was 51% at 60 months. Fontan conversion and CA were similar with regard to AR (P = .14) and significantly better compared with AAD (P < .0001). Adverse events were found to occur more frequently in the patients with AR (P < .0001) and the patients treated with AAD only (P < .0001).
Conclusions:
Catheter ablation and FC operations are associated with less recurrence of atrial tachyarrhythmia compared with AAD. Atrial tachyarrhythmias are more likely to recur in patients with a longer history of the arrhythmia and are associated with more adverse events. Early referral to a specialty center for these interventions should be considered.
More Related Videos
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias II: Classification of Tachyarrhythmias
Aortic Regurgitation III: Medical Management
Dysrhythmias IV: Characteristics of Bradyarrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias VII: Nursing Management of Dysrhythmias

